#Pharma #Biotech Durham’s Bioventus acquires portfolio of therapies from Pfizer NewsObserver http://t.co/nWTc0Cg9ul
July 03, 2013
Publicité
/http%3A%2F%2Fwww.newsobserver.com%2Fmistatic%2Fimages%2Flogo%2FNewsObserver2_footer.png)
Durham's Bioventus acquires portfolio of therapies from Pfizer
Durham-based Bioventus has acquired exclusive worldwide rights to develop a new generation of therapies from pharmaceutical giant Pfizer. The deal, announced this week, was the first acquisition by Bioventus since it was spun out of medical technology giant Smith & Nephew last year. More deals are a distinct possibility.